Myomo, Inc. (MYO) vs TELA Bio, Inc. (TELA)
Myomo, Inc. and TELA Bio, Inc. are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $64.6M against $57.3M — 1.1× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against 6.09%. Myomo, Inc. has the higher net margin (−33.5% vs −51.5%) and the higher return on invested capital (−167.9% vs −217.1%). Across the 17 metrics below, Myomo, Inc. leads on 10 and TELA Bio, Inc. on 7.
Valuation
Profitability
| Metric | MYO | TELA | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.35% | 68.29% | 56.01% |
| Operating margin | (27.05%) | (42.56%) | (15.03%) |
| Net margin | (33.53%) | (51.53%) | (20.40%) |
| Free cash flow margin | (21.01%) | (39.57%) | (7.24%) |
| Return on equity | (123.76%) | 1,232.54% | (15.32%) |
| Return on assets | (39.20%) | (64.71%) | (19.72%) |
| Return on invested capital | (167.90%) | (217.11%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack